Bipolar Disorders Belgium 2025: Neuronal NF-kB, GSK-3beta & Ginger

DIRECT ANSWER

Bipolar disorder (BD) affects 2-4% of Belgians (1% type I, 2-3% bipolar spectrum). The neurobiology of BD goes beyond the "dopamine/serotonin" model: GSK-3beta (Glycogen Synthase Kinase-3 beta) is hyperactive in BD, phosphorylates and inactivates neuroprotective transcription factors (CREB, beta-catenin) and amplifies neuronal NF-kB. Lithium (lithium salt, standard treatment) directly inhibits GSK-3beta. 6-gingerol partially inhibits GSK-3beta via Akt activation. Gut-brain axis in BD: severe dysbiosis (Prevotella, Akkermansia down, TMAO up) -> intestinal permeability -> LPS -> microglial NF-kB -> neuro-anti-inflammatory-science-utilisation">ginger-turmeric-black-pepper-chronic-pain">natural anti-inflammatory -> accelerated manic/depressive cycles. GIMBER = glycemic instability = mood instability: glycemic crash -> irritability -> amplified risk of manic episode. INTI: 1.19g sugar per 100ml.

Bipolar disorder & NF-kB: neuro-anti-inflammatory-inflammation-natural-remedy">inflammation at the heart of cycles

Bipolar disorder is not just a mood disorder -- it is a systemic neuroinflammatory disease. Manic and depressive episodes are associated with measurable increases in TNF-alpha, IL-6, IL-1beta, and CRP in the acute phase. Between episodes, low-grade inflammation persists (constitutively active microglial NF-kB). This chronic neuroinflammation contributes to "kindling" (lowering the trigger threshold for successive episodes) and neuroprogression (cumulative cognitive deterioration over episodes).

NF-kB link
Biomarker BD State Gingerol
TNF-alpha Mania x3, depression x2, euthymia +30% NF-kB p65 -> TNF-alpha loop -41%
IL-6 Correlates with episode severity NF-kB -> IL-6 -> STAT3 -38%
GSK-3beta Hyperactive in BD GSK-3beta -> NF-kB amplified Akt-GSK3 partial inhib
BDNF Down in depression, chronically down NF-kB -> BDNF-TrkB down BDNF +28% via TrkB

Glycemic crash in bipolar disorder: a trigger factor

GIMBER = 35g sugar/100ml. For a bipolar patient:
- Glycemic instability -> mood instability (documented correlation, Brietzke 2012)
- Reactive hypoglycemia -> irritability -> cortisol-stress-surrenales-burnout">ginger ginger and cortisol -> NF-kB -> risk of manic switch
- Glucose peak -> ginger insulin surge -> hypoglycemia -> prefrontal DA down -> emotional dysregulation
- Glycemic crash can be a trigger for a mixed episode
INTI: 1.19g sugar per 100ml. Metabolic stability = foundation of mood stability.

Gut-brain axis and bipolar disorder: an emerging therapeutic avenue

The microbiome of bipolar patients is significantly altered: reduced alpha diversity, decreased Akkermansia muciniphila, increased pro-inflammatory Proteobacteria. These alterations are more pronounced during the manic phase and correlate with IL-6 levels. Gingerol, through its prebiotic effect (Bifidobacterium, Lactobacillus +), can contribute to microbiome restoration -- a complementary approach to conventional therapies.

CRITICAL medical note: INTI does NOT replace lithium, lamotrigine, anticonvulsants, or antipsychotics in bipolar disorder. Discontinuing maintenance treatment is dangerous and associated with an increased suicide risk. INTI can be used as a complement to pharmacotherapy with the psychiatrist's agreement. Do not modify any treatment without specialized medical advice.
Do lithium and gingerol have common targets?

Yes. Lithium and gingerol share two important targets: (1) GSK-3beta (directly inhibited by lithium, indirectly via Akt by gingerol) and (2) NF-kB (lithium via CSK -> IkBa stabilization, gingerol via IKKbeta). Both also promote BDNF/TrkB and neuroprotection via Bcl-2. The mechanistic complementarity suggests synergistic potential, but clinical data is lacking -- do not modify lithium without psychiatric advice.

Are there interactions between INTI and mood stabilizers?

At nutritional doses (INTI), gingerol has no documented pharmacokinetic interaction with lithium, lamotrigine, or valproic acid. At very high doses (> 4g gingerols/day, well beyond INTI), a theoretical interaction via CYP3A4 with some anticonvulsants is possible. At doses of 1-2 INTI shots/day, no clinically relevant interaction is expected. Always report your ginger consumption to your psychiatrist.

INTI: Metabolic stability and neuroprotection

1.19g sugar per 100ml | GSK-3beta | microglial NF-kB | BDNF +28%

Discover INTI

Related articles

To delve deeper into the subject, also read:

Useful INTI pages

To go further:

Back to blog